# BIfurcation Optimal Treatment Strategy With LYMus Eluting Dedicated Bifurcation Versus Convention Stent Randomized Study

> **NCT01430364** · PHASE4 · UNKNOWN · sponsor: **Medica Cor Heart Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Bifurcation Stenosis

## Interventions

- **DEVICE:** BIOSS LIM implantation
- **DEVICE:** BIOSS Lim
- **DEVICE:** CarloS

## Key facts

- **NCT ID:** NCT01430364
- **Lead sponsor:** Medica Cor Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2013-12
- **Final completion:** 2014-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-12-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01430364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01430364, "BIfurcation Optimal Treatment Strategy With LYMus Eluting Dedicated Bifurcation Versus Convention Stent Randomized Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01430364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*